RE: ‘’They’re trying to take your cheap shares’’17 Aug 2022 10:05
Given the total incompetence exhibited by Marsden and the after school science club I am beginning to doubt that Synairgen 's" cast iron/ set in stone patents won't stand up to legal scrutiny which is probably why nobody as taken a punt buying the drug .The company is pretty worthless as is the BOD / scientists who did their bit decades ago on this drug .
The French will probably take interferon therapy forward which, as a lot of the so called investors say on here " Will be a good thing if it saves lives"
Thats Absolute $h!te, This drug has only been good for one thing and that was fulfilling numis expectation of £9.90 a share which is now the stuff of total fantasy .
Any pharma must have done their diligence and assessed that this drug could be purchased outright for around £300 million now with another £ 50 million to get the drug approved .Yet ,not a single offer???.